Myofibrillogenesis in the first cardiomyocytes formed from isolated quail precardiac mesoderm.
De novo assembly of myofibrils was investigated in explants of precardiac mesoderm from quail embryos to address a controversy about different models of myofibrillogenesis. The sequential expression of sarcomeric components was visualized in double- and triple-stained explants before, during, and just after the first cardiomyocytes began to beat. In explants from stage 6 embryos, cultured for 10 h, ectoderm, endoderm, and the precardiac mesoderm displayed arrays of stress fibers with alternating bands of the nonmuscle isoforms of alpha-actinin and myosin IIB. With increasing time in culture, mesoderm cells contained fibrils composed of actin, nonmuscle myosin IIB, and sarcomeric alpha-actinin. Several hours later, before beating occurred, both nonmuscle and muscle myosin II localized in some of the fibrils in the cells. Concentrations of muscle myosin began as thin bundles, dispersed in the cytoplasm, often overlapping one another, and progressed to small, aligned A-band-sized aggregates. The amount of nonmuscle myosin decreased dramatically when Z-bands formed, the muscle myosin became organized into A-bands, and the cells began beating. The sequential changes in protein composition of the fibrils in the developing muscle cells supports the model of myofibrillogenesis in which assembly begins with premyofibrils and progresses through nascent myofibrils to mature myofibrils.
Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6058, USA.
Aiping
A
Du
Jean M
JM
Sanger
Kersti K
KK
Linask
Joseph W
JW
Sanger
D000185:Actinin / Q000378:metabolism; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D002455:Cell Division / Q000502:physiology; D003370:Coturnix / Q000196:embryology*; D004475:Ectoderm / Q000378:metabolism; D004625:Embryo, Nonmammalian; D004707:Endoderm / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000196:embryology*; D008648:Mesoderm / Q000166:cytology / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D009210:Myofibrils / Q000187:drug effects / Q000502:physiology*; D024462:Myosin Type II / Q000378:metabolism; D009219:Myosin-Light-Chain Kinase / Q000037:antagonists & inhibitors; D009281:Naphthalenes / Q000494:pharmacology; D009924:Organ Culture Techniques; D012518:Sarcomeres
D001381:Azepines; D004791:Enzyme Inhibitors; D009281:Naphthalenes; C070571:ML 7; D000185:Actinin; D009219:Myosin-Light-Chain Kinase; D024462:Myosin Type II